HIV Universal Vaccine

  • Marek Malecki Phoenix Biomolecular Engineering Foundation (PBMEF), San Francisco, CA, USA
  • Bianka Saetre Phoenix Biomolecular Engineering Foundation (PBMEF), San Francisco, CA, USA
Keywords: Huma n Immu n o d e f i c i e n c y Vi r u s, Huma n Immunodeficiency Virus Vaccine, HIV, Hepatitis B Virus, Hepatitis B Virus Vaccine, HBV, Human Papilloma Virus, HPV, Human Papilloma Virus Vaccine, HPVV, Cluster of Differentiation 4, glycoprotein 120, Acquired Immunodeficiency Syndrome, AIDS, Vaccine, Virus Universal Vaccine

Abstract

Abstract: For many deadly viruses, there are no preventive and / or therapeutic vaccines approved by health authorities World-wide (e.g., HIV, Ebola, Dengue, and many others). Although, for some viruses, prophylactic vaccines are very effective (e.g., HBV, Polio, Rota, and many others). In this realm, we design, manufacture, test, and streamline into the clinics novel viral universal vaccines (VUV). VUV have such unique features, that medical vaccination or natural infection induced immunity against some viruses (e.g., HBV) in patients, who became infected with other viruses (e.g., HIV), upon the VUV’s administration , is redirected against these other, newly infecting viruses (e.g., HIV).

 

Downloads

Download data is not yet available.

Author Biographies

Marek Malecki, Phoenix Biomolecular Engineering Foundation (PBMEF), San Francisco, CA, USA

here is the corresponding author bio statement

Bianka Saetre, Phoenix Biomolecular Engineering Foundation (PBMEF), San Francisco, CA, USA

Here is my bio statement

References

References

WHO. Infectious Diseases. http://www.who.int/topics/ infectious_diseases/factsheets/en/ downloaded 01Jan2018

F a u c i A S ; L a n e H C . C h a p t e r 2 2 6 : H u m a n Immunodeficiency Virus Disease: AIDS and Related Disorders. https://accessmedicine.mhmedical.com/ content.aspx?bookid=1130&sectionid=79738808

In: Dennis Kasper, Anthony Fauci, Stephen Hauser, Dan Longo, J. Larry Jameson, Joseph Loscalzo eds. Harrison’s Internal Medicine. 19th edition. https:// accessmedicine. mhmedical. com/ book. aspx?bookID=1130 downloaded 01Jan2018

WHO Immunization, Vaccines and Biologicals http:// www.who.int/immunization/diseases/en/ downloaded 01Jan2018

CDC. List of Vaccines Used in United States https://www.cdc.gov/vaccines/vpd/vaccines-list.html downloaded 01Jan2018

F D A . V a c c i n e s . h t t p s : / / w w w . f d a . g o v /

BiologicsBloodVaccines/Vaccines/ downloaded 01Jan2018

NIH. AIDS. Fact sheet – Preventive vaccine. https://aidsinfo.nih.gov/understanding-hiv-aids/fact- sheets/19/96/what-is-a-preventive-hiv-vaccine-

NIH. AIDS. Fact sheet – Therapeutic vaccine. https://aidsinfo.nih.gov/understanding-hiv-aids/fact- sheets/19/91/what-is-a-therapeutic-hiv-vaccine- downloaded 01Jan2018

Acosta EP, Flexner C. Chapter 58 . Antiviral Agents. In: Brunton L. Goodman and Gilman’s The Pharmacological Basis of Therapeutics. 12th edition. https://accessmedicine.mhmedical.com/ downloaded 01Jan2018

Flexner C. Chapter 59. Antiretroviral Agents and Treatment of HIV Infection. In: Brunton L. Goodman and Gilman’ s The Pharmacological Basis of Therapeutics. 12th edition. https://accessmedicine. mhmedical.com/ downloaded 01Jan2018

NIH. AIDS. Fact sheet - Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents Living with HIV https://aidsinfo.nih.gov/drugs downloaded 01Jan2018

NIH. AIDS. Fact sheet - HIV medicines and side effects. https://aidsinfo.nih.gov/understanding-hiv- aids/fact-sheets/22/63/hiv-medicines-and-side-effects downloaded 01Jan2018

Cummins NW, Sainski AM, Natesampillai S, Bren GD, Badley AD. Choice of antiretroviral therapy differentially impacts survival of HIV-infected CD4 T cells. Mol Cell Ther. 2014; 2:1.

Cummins NW, Rizza S, Litzow MR, Hua S, Lee GQ, Einkauf K, Chun TW, Rhame F, Baker JV, Busch MP, Chomont N, Dean PG, Fromentin R, Haase AT, Hampton D, Keating SM, Lada SM, Lee TH, Natesampillai S, Richman DD, Schacker TW, Wietgrefe S, Yu XG, Yao JD, Zeuli J, Lichterfeld M, Badley AD. Extensive virologic and immunologic characterization in an HIV-infected individual following allogeneic stem cell transplant and analytic cessation of antiretroviral therapy: A case study. PLoS Med. 2017 Nov 28;14(11): e1002461.

Dagleish AG, Beverly PCL, Clapham PR, Crawford DH, Greaves MF, Weiss RA. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 1983; 312:763-765.

Klatzmann D., Champagne E, Charamet S, Gruest J, Guetard D, Hercend T, Gluckman J-C, Montagnier L. T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature 1983; 312, 766-767.

Traunecker A1, Lüke W, Karjalainen K. Soluble CD4 molecules neutralize human immunodeficiency virus type 1. Nature 1988; 331(6151):84-6.

Fisher RA1, Bertonis JM, Meier W, Johnson VA, Costopoulos DS, Liu T, Tizard R, Walker BD, Hirsch MS, Schooley RT, et al. HIV infection is blocked in vitro by recombinant soluble CD4. Nature. 1988; 331(6151):76-8.

Bruel T, Guivel-Benhassine F, Amraoui S, Malbec M,

Richard L, Bourdic K, Donahue DA, Lorin V, Casartelli N, Noël N, Lambotte O, Mouquet H, Schwartz O. Elimination of HIV-infected cells by broadly neutralizing antibodies. Nature Communications 2016; 3; 7:10844.

Hodges TL, Kahn JO, Kaplan LD, et al. 1991. Phase

study of recombinant CD4-Immunoglobulin G therapy of patients with AIDS. Antimrobial Agents and Chemotherapy. 1991; 35 (12): 2580-2586.

Hodges TL, Kahn JO, Kaplan LD, et al. 1991. Phase 1 study of recombinant CD4-Immunoglobulin G therapy of patients with AIDS. Antimicrobial Agents and Chemotherapy. 1991; 35 (12): 2580-2586

Arthos J, Cicala C, Steenbeke TD, et al. Biochemical characterization of dodecameric CD4-Ig fusion protein. J. Biol. Chem. 2002; 277 (130: 11456-11464.

Bosch B, Blanco J, Pauls E., et al. Inhibition of co- receptor – independent cell- to- cell Human Immunodeficiency Virus type 1 transmission by CD4- Immunoglobulin G2 fusion protein. 2005; 49 (10): 4296-4305.

Kim JH, Excler JL, Michael NL. Lessons from the RV144 Thai phase III HIV-1 vaccine trial and the search for correlates of protection. Annu Rev Med. 2015; 66: 423- 37. doi: 10. 1146/ annurev- med-052912-123749. Epub 2014 Oct 17.

Excler JL, Robb ML, Kim JH. Prospects for a globally effective HIV-1 vaccine.Vaccine. 2015;33 Suppl 4: D4-12.

Malecki M, Hsu A, Truong L, Sanchez S. Molecular immunolabeling with recombinant single-chain variable fragment (scFv) antibodies designed with metal binding domains. Proc. Natl. Acad. Sci. U. S. A. 2001; 99, 213-219.

Malecki M, Szybalski W. Isolation of single, intact chromosomes from single, selected ovarian cancer cells for in situ hybridization and next generation sequencing. Gene. 2012; 493(1): 132-139.

Szybalska EH, Szybalski W. Genetics of human cell line. IV. DNA-mediated heritable transformation of a biochemical trait. Proc. Natl. Acad. Sci. U.S.A. 1962; 48:2026-2034.

Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate- phenol-chloroform extraction. Anal. Biochem. 1987; 162:156-159.

Malecki M, Putzer E, Caroline Quach C, DodivenakaC, Tombokan X. Novel paradigm for immunotherapy of breast cancer by engaging prophylactic immunity against hepatitis B. Clin Trans Med 2016; 5(32):1-12.

Malecki M, Sabo C, Foorohar A, Tombokan X. Novel paradigm for immunotherapy of ovary cancer by engaging prophylactic immunity against hepatitis B. Clin Trans Med 2016; 5(44):1-16.

Barre-Sinoussi F, Chermann JD, Rey F, et al: Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 1983, 220:868-871.

Gallo RC, Sarin PS, Gelmann EP, et al: Isolation of human T-cell leukemia virus in acquired immune

deficiency syndrome ( AIDS). Science 1983 , 220:865-868

Popovic M, Sarngadharan MG, Read E, et al: Detection, isolation and continuous production of cytopathic retrovirus (HTLV-III) from patients with AIDS and pre-AIDS. Science 1984, 224:497-500.

Gallo D, Kimpton JS, Dailey PJ. Comparative studies on use of fresh and frozen peripheral blood lymphocyte specimens for isolation of human immunodeficiency virus and effects of cell lysis on isolation efficiency. J Clin Microbiol. 1987; 25(7):1291-4.

Yourno J, Conroy J. A novel polymerase chain reaction method for detection of human immunodeficiency virus in dried blood spots on filter paper. J Clin Microbiol. 1992; 30(11):2887-92.

van Bueren J, Simpson RA, Jacobs P, Cookson BD. Survival of human immunodeficiency virus in suspension and dried onto surfaces. J Clin Microbiol. 1994 Feb;32(2):571-4.

Yourno J. Direct polymerase chain reaction for detection of human immunodeficiency virus in blood spot residues on filter paper after elution of antibodies: an adjunct to serological surveys for estimating vertical transmission rates among human immunodeficiency virus antibody-positive newborns. J Clin Microbiol. 1993; 31(5):1364-1367.

Wain-Hobson S, Sonigo P, Danos O, Cole S, Alizon

M. Nucleotide sequence of the AIDS virus, LAV. Cell. 1985; 40(1):9-17.

Kwok S, Mach DH, Mullis KB, Poiesz B, Ehrlich G, Blair D, Friedman-Kien A, Sninsky JJ. Identification of human immunodeficiency virus sequences by using in vitro enzymatic amplification and oligomer cleavage detection. J. Virol. 1987; 61:1690-1694.

Wong-Staal F, Gallo RC, Chang NT, Ghrayeb J, Papas TS, Lautenberger JA, Pearson ML, Petteway SR Jr., Ivanoff L, Baumeister K, Whitehorn EA, Rafalski JA, Doran ER, Josephs SJ, Starcich B, Livak KJ, Patarca R, Haseltine WA, Ratner L. Complete nucleotide sequence of the AIDS virus, HTLV-III Nature 1985; 313 (6000): 277-284.

Muesing MA, Smith DH, Cabradilla CD, Benton CV, Lasky LA, Capon DJ. Nucleic acid structure and expression of the human AIDS/lymphadenopathy retrovirus. Nature 1985; 313 (6002): 450-458.

Maddon JP, Molineaux SE, Maddon DE, Zimmerman KA, Godfrey M, Alt FW, Chess L, Axel, R. Structure and expression of the human and mouse T4 genes. Proc. Natl. Acad. Sci. U.S.A. 1987; 84:9155-9159.

Molday RS, Yen SPS, Rembaum A. Application of magnetic microspheres in labelling and separation of cells. Nature 1977; 268: 437-438.

Glazer JK, Malecki M , Grist TM. Targeted MRI Contrast Agent Using Bioengineered scFv Fragments with Gadolinium Labelled Metal Binding Domain. INSRM 2004; 12: 001713

Malecki M. HER2/neu gene expression products evaluated with superparamagnetic single chain variable fragment (scFv) antibodies. Proc S Dak Acad

Sci. 2007; 86:297-308

Malecki M, L’Vanne K, Truong L, Hsu A, Hogan C , A l b r e c h t R . S u p r a m o l e c u l a r I m a g i n g o f Immunolabeling with STEM EDX & EEL SI Microscopy and Microanalysis; Cambridge 2004; 10( S02): 1216-1217.

S ö f f g e F, v o n H ö r s t e n W. A c - s u s c e p t i b i l i t y m e a s u r e m e n t s i n s m a l l f i e l d s o n f i n e superparamagnetic nickel particles. Zeitschrift für Physik B Condensed Matter. 1981; 42: 47–55

Turkevich J, Stevenson PC, Hillier J. A study of the nucleation and growth processes in the synthesis of colloidal gold. Discussions of the Faraday Society. 1951; 11: 1-7.

Stöber W, Fink A, Bohn E. Controlled growth of

monodisperse silica spheres in the micron size range. Journal of Colloid and Interface Science. 1968; 26 (1):

–69.

Krejcarek GE, Tucker KL. Covalent attachment of chelating groups to macromolecules. Biochem Biophys Res Commun. 1977 Jul 25; 77(2):581-5.

Meares CF, Goodwin DA, Leung CS, Girgis AY, Silvester DJ, Nunn AD, Lavender PJ. Covalent attachment of metal chelates to proteins: the stability in vivo and in vitro of the conjugate of albumin with a chelate of 111indium. Proc Natl Acad Sci U S A. 1976; 73(11):3803-3806.

Malecki M., Saetre B. HIV Apheresis Tags (HIVAT) aided elimination of viremia. Molecular and Cellular Therapies, 2018, 6.

Published
2018-11-06
How to Cite
Malecki, M., & Saetre, B. (2018). HIV Universal Vaccine. <font Color="white">Molecular and Cellular Therapies</Font&gt;, 2018(1), 1-14. https://doi.org/10.26781/2052-8426-2018-05
Section
Research Article